Analgesia

for treating homozygous familial hypercholesterolaemia (HoFH)

For treatment of CKD in Type 2 diabetes as per TA877.

(Not currently licensed for use in heart failure)

For severe chronic ischaemia of lower limbs and severe Raynaud’s syndrome

PURPLE (recommendation without supply): IR Capsules for Raynaud’s syndrome. Second line to MR if MR is clinically inappropriate or not tolerated.

For information regarding the use of nifedipine in the prophylaxis of Raynaud’s phenomenon please see CKS guidance here:

Scenario: Management | Management | Raynaud's phenomenon | CKS | NICE

Patiromer Medicine Information Leaflet

RED - for acute hyperkalaemia.

PURPLE - for treating hyperkalaemia according to NICE TA623.

Lokelma Medicine Information Sheet

RED - for acute hyperkalaemia.

PURPLE - for treatment of persistent hyperkalaemia in adult patients with CKD 3b-c or heart failure.